DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells

Oncogene

Volumn 27, Issue 46, 2008, Pages 6034-6043

  Garcia Aragoncillo E ^a   Carrillo, J ^a   Lalli, E ^b   Agra, N ^a   Gomez Lopez G ^c,d   Pestaa A ^a   Alonso, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c Hospital Dorrebullón   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

DAX1; Ewing's tumors; EWS FLI1 oncoprotein; NR0B1; RNA interference

Indexed keywords

CELL CYCLE PROTEIN 6; CYCLIN DEPENDENT KINASE 2; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 10; NUCLEAR RECEPTOR DAX 1; ONCOPROTEIN; RNA BINDING PROTEIN EWS; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR FLI 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CONTROLLED STUDY; EMBRYO; EWING SARCOMA; GENE EXPRESSION PROFILING; GENOME ANALYSIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL;

ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

MUS;

EID: 53649107137     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.203     Document Type: Article

References (36)

1. Altincicek B, Tenbaum SP, Dressel U, Thormeyer D, Renkawitz R, Baniahmad A. (2000). Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 275: 7662-7667.
2. Arvand A, Denny CT. (2001). Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. (2000). Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25: 25-29.
4. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G et al. (1994). A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 7: 497-501.
5. Carrillo J, Garcia-Aragoncillo E, Azorin D, Agra N, Sastre A, Gonzalez-Mediero I et al. (2007). Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Clin Cancer Res 13: 2429-2440.
6. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. (1998). Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 18: 2949-2956.
7. De Alava E, Gerald WL. (2000). Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18: 204-213.
8. Ferreira BI, Alonso J, Carrillo J, Acquadro F, Largo C, Suela J et al. (2008). Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene 27: 2084-2090.
9. Guo W, Burris TP, Zhang YH, Huang BL, Mason J, Copeland KC et al. (1996). Genomic sequence of the DAX1 gene: an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. J Clin Endocrinol Metab 81: 2481-2486.
10. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG et al. (1999). Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23: 222-227.
11. Holter E, Kotaja N, Makela S, Strauss L, Kietz S, Janne OA et al. (2002). Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 16: 515-528.
12. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA. (2003). Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
13. Ito M, Yu R, Jameson JL. (1997). DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 17: 1476-1483.
14. Janknecht R. (2005). EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 363: 1-14.
15. Kim S, Denny CT, Wisdom R. (2006). Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins. Mol Cell Biol 26: 2467-2478.
16. Kinsey M, Smith R, Lessnick SL. (2006). NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 4: 851-859.
17. Kovar H. (1998). Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol 10: 334-342.
18. Kovar H. (2005). Context matters: the hen or egg problem in Ewing's sarcoma. Semin Cancer Biol 15: 189-196.
19. Lalli E, Sassone-Corsi P. (2003). DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 17: 1445-1453.
20. Luckow B, Schutz G. (1987). CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15: 5490.
21. Mendiola M, Carrillo J, Garcia E, Lalli E, Hernandez T, De Alava E et al. (2006). The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer 118: 1381-1389.
22. Nakatani F, Tanaka K, Sakimura R, Matsumoto Y, Matsunobu T, Li X et al. (2003). Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J Biol Chem 278: 15105-15115.
23. Nishimori H, Sasaki Y, Yoshida K, Irifune H, Zembutsu H, Tanaka T et al. (2002). The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21: 8302-8309.
24. Prieur A, Tirode F, Cohen P, Delattre O. (2004). EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol 24: 7275-7283.
25. Reiner A, Yekutieli D, Benjamini Y. (2003). Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375.
26. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N et al. (2003). TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
27. Song KH, Park YY, Park KC, Hong CY, Park JH, Shong M et al. (2004). The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 18: 1929-1940.
28. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G et al. (2004). DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64: 8213-8221.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
30. Suzuki T, Kasahara M, Yoshioka H, Umesono K, Morohashi K. (2002). LXXLL motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Endocr Res 28: 537.
31. Tamai KT, Monaco L, Alastalo TP, Lalli E, Parvinen M, Sassone-Corsi P. (1996). Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 10: 1561-1569.
32. Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. (1997). EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 99: 239-247.
33. Wasylyk B, Hahn SL, Giovane A. (1993). The Ets family of transcription factors. Eur J Biochem 211: 7-18.
34. Welford SM, Hebert SP, Deneen B, Arvand A, Denny CT. (2001). DNA binding domain-independent pathways are involved in EWS/ FLI1-mediated oncogenesis. J Biol Chem 276: 41977-41984.
35. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W et al. (1994). An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372: 635-641.
36. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. (2000). DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 275: 39855-39859.